Shorepoint Capital Partners’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$7.46M Buy
2025
Q1
$6.97M Sell
2024
Q4
$6.2M Sell
2024
Q3
$6.94M Sell
2024
Q2
$6.36M Sell
2024
Q1
$6.76M Sell
2023
Q4
$6.11M Sell
2023
Q3
$6.92M Sell
2023
Q2
$6.71M Sell
2023
Q1
$8.49M Sell
2022
Q4
$9.79M Buy
2022
Q3
$6.57M Buy
2022
Q2
$7.39M Sell
2022
Q1
$8.4M Sell
2021
Q4
$7.55M Buy
2021
Q3
$5.97M Buy
2021
Q1
$5.28M Sell
2020
Q4
$8.18M Buy
2020
Q3
$6.68M Sell
2020
Q2
$7.76M Sell
2020
Q1
$6.87M Sell
2019
Q4
$8.41M Sell
2019
Q3
$7.28M Buy
2019
Q2
$6.78M Buy
2019
Q1
$7.02M Buy